一名镰状细胞病患者服用羟基脲后发生干性坏疽：病例报告 - Suppr

Suppr

超能文献

Dry gangrene in a patient with sickle cell disease on hydroxyurea: a case report.

作者信息

Bhangu Gurjeet, Uminski Kelsey, Roessner Cameron, Goodyear Dawn, Sale Trudy, Rydz Natalia

机构信息

Department of Medicine, University of Calgary, Calgary, AB, Canada.

Southern Alberta Rare Blood and Bleeding Disorders Comprehensive Care Program, Calgary, AB, Canada.

出版信息

Ann Hematol. 2024 Aug;103(8):3277-3279. doi: 10.1007/s00277-024-05732-w. Epub 2024 Apr 17.

DOI:10.1007/s00277-024-05732-w

PMID:38630130

Abstract

摘要

相似文献

Dry gangrene in a patient with sickle cell disease on hydroxyurea: a case report.

Ann Hematol. 2024 Aug;103(8):3277-3279. doi: 10.1007/s00277-024-05732-w. Epub 2024 Apr 17.

Ann Intern Med. 2011 Nov 15;155(10):722-4. doi: 10.7326/0003-4819-155-10-201111150-00024.

Hydroxyurea for sickle cell anemia.

N Engl J Med. 2008 Jul 3;359(1):98; author reply 98-9.

Hydroxyurea for the treatment of sickle cell anemia.

N Engl J Med. 2008 Mar 27;358(13):1362-9. doi: 10.1056/NEJMct0708272.

Hydroxyurea in very young children with sickle cell anemia is not a cure-all.

J Pediatr. 2001 Dec;139(6):763-4. doi: 10.1067/mpd.2001.120093.

Hydroxyurea therapy for sickle cell disease in Britain. Disappointing recruitment despite promising results.

BMJ. 1998 Jun 6;316(7146):1689. doi: 10.1136/bmj.316.7146.1689.

Hydroxyurea for sickle-cell anaemia in Africa: mind the gap.

Lancet Glob Health. 2015 Mar;3(3):e124-5. doi: 10.1016/S2214-109X(14)70371-7.

[Edifying affair of hydroxycarbamid].

Rev Med Suisse. 2008 Apr 9;4(152):940.

Sickle cell pain crisis.

Lancet. 1996 Jan 27;347(8996):263.

Hydroxycarbamide for sickle-cell anaemia in infancy.

Lancet. 2011 May 14;377(9778):1628-30. doi: 10.1016/S0140-6736(11)60511-4.

本文引用的文献

Leg Ulcers in Sickle-Cell Disease: Treatment Update.

Adv Wound Care (New Rochelle). 2020 Jun;9(6):348-356. doi: 10.1089/wound.2018.0918. Epub 2019 Apr 24.

Autoamputation of diabetic toe with dry gangrene: a myth or a fact?

Diabetes Metab Syndr Obes. 2018 Jun 1;11:255-264. doi: 10.2147/DMSO.S164199. eCollection 2018.

Critical Reviews: How we treat sickle cell patients with leg ulcers.

Am J Hematol. 2016 Jan;91(1):22-30. doi: 10.1002/ajh.24134. Epub 2015 Aug 14.

Hyperbaric oxygen therapy for chronic wounds.

Cochrane Database Syst Rev. 2015 Jun 24;2015(6):CD004123. doi: 10.1002/14651858.CD004123.pub4.

Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease.

Ann Intern Med. 2008 Jun 17;148(12):939-55. doi: 10.7326/0003-4819-148-12-200806170-00221. Epub 2008 May 5.

Gangrene of the toes in a patient with chronic myelogenous leukemia after long-term hydroxyurea therapy.

Ann Hematol. 2002 Aug;81(8):467-9. doi: 10.1007/s00277-002-0505-0. Epub 2002 Aug 15.

Mucocutaneous adverse effects of hydroxyurea: a prospective study of 30 psoriasis patients.

Clin Exp Dermatol. 2002 Jan;27(1):8-13. doi: 10.1046/j.0307-6938.2001.00947.x.

Muco-cutaneous changes during long-term therapy with hydroxyurea in chronic myeloid leukaemia.

Clin Exp Dermatol. 2001 Mar;26(2):141-8. doi: 10.1046/j.1365-2230.2001.00782.x.

Cutaneous adverse reactions to hydroxyurea in patients with sickle cell disease.

Arch Dermatol. 2001 Apr;137(4):467-70.

Hydroxyurea-induced gangrene of the toes in a patient with chronic myelogenous leukemia.

Am J Hematol. 2000 Feb;63(2):103-4. doi: 10.1002/(sici)1096-8652(200002)63:2<103::aid-ajh11>3.0.co;2-n.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Dry gangrene in a patient with sickle cell disease on hydroxyurea: a case report.

Ann Hematol. 2024 Aug;103(8):3277-3279. doi: 10.1007/s00277-024-05732-w. Epub 2024 Apr 17.

Ann Intern Med. 2011 Nov 15;155(10):722-4. doi: 10.7326/0003-4819-155-10-201111150-00024.

Hydroxyurea for sickle cell anemia.

N Engl J Med. 2008 Jul 3;359(1):98; author reply 98-9.

Hydroxyurea for the treatment of sickle cell anemia.

N Engl J Med. 2008 Mar 27;358(13):1362-9. doi: 10.1056/NEJMct0708272.

Hydroxyurea in very young children with sickle cell anemia is not a cure-all.

J Pediatr. 2001 Dec;139(6):763-4. doi: 10.1067/mpd.2001.120093.

Hydroxyurea therapy for sickle cell disease in Britain. Disappointing recruitment despite promising results.

BMJ. 1998 Jun 6;316(7146):1689. doi: 10.1136/bmj.316.7146.1689.

Hydroxyurea for sickle-cell anaemia in Africa: mind the gap.

Lancet Glob Health. 2015 Mar;3(3):e124-5. doi: 10.1016/S2214-109X(14)70371-7.

[Edifying affair of hydroxycarbamid].

Rev Med Suisse. 2008 Apr 9;4(152):940.

Sickle cell pain crisis.

Lancet. 1996 Jan 27;347(8996):263.

Hydroxycarbamide for sickle-cell anaemia in infancy.

Lancet. 2011 May 14;377(9778):1628-30. doi: 10.1016/S0140-6736(11)60511-4.

本文引用的文献

Leg Ulcers in Sickle-Cell Disease: Treatment Update.

Adv Wound Care (New Rochelle). 2020 Jun;9(6):348-356. doi: 10.1089/wound.2018.0918. Epub 2019 Apr 24.

Autoamputation of diabetic toe with dry gangrene: a myth or a fact?

Diabetes Metab Syndr Obes. 2018 Jun 1;11:255-264. doi: 10.2147/DMSO.S164199. eCollection 2018.

Critical Reviews: How we treat sickle cell patients with leg ulcers.

Am J Hematol. 2016 Jan;91(1):22-30. doi: 10.1002/ajh.24134. Epub 2015 Aug 14.

Hyperbaric oxygen therapy for chronic wounds.

Cochrane Database Syst Rev. 2015 Jun 24;2015(6):CD004123. doi: 10.1002/14651858.CD004123.pub4.

Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease.

Ann Intern Med. 2008 Jun 17;148(12):939-55. doi: 10.7326/0003-4819-148-12-200806170-00221. Epub 2008 May 5.

Gangrene of the toes in a patient with chronic myelogenous leukemia after long-term hydroxyurea therapy.

Ann Hematol. 2002 Aug;81(8):467-9. doi: 10.1007/s00277-002-0505-0. Epub 2002 Aug 15.

Mucocutaneous adverse effects of hydroxyurea: a prospective study of 30 psoriasis patients.

Clin Exp Dermatol. 2002 Jan;27(1):8-13. doi: 10.1046/j.0307-6938.2001.00947.x.

Muco-cutaneous changes during long-term therapy with hydroxyurea in chronic myeloid leukaemia.

Clin Exp Dermatol. 2001 Mar;26(2):141-8. doi: 10.1046/j.1365-2230.2001.00782.x.

Cutaneous adverse reactions to hydroxyurea in patients with sickle cell disease.

Arch Dermatol. 2001 Apr;137(4):467-70.

Hydroxyurea-induced gangrene of the toes in a patient with chronic myelogenous leukemia.

Am J Hematol. 2000 Feb;63(2):103-4. doi: 10.1002/(sici)1096-8652(200002)63:2<103::aid-ajh11>3.0.co;2-n.